Belenos Biosciences is a clinical-stage biotech developing immunotherapies for chronic inflammatory diseases, including asthma, chronic obstructive pulmonary disease, and atopic dermatitis. Founded in 2024, the…
Corvus Pharmaceuticals, founded in 2014, develops targeted therapies designed to modulate the immune system. Its pipeline includes Soquelitinib, Ciforadenant, and Mupadolimab. These programs focus on…
Helicore Biopharma has emerged as a notable player in obesity therapeutics research through its work on neutralizing the glucose-dependent insulinotropic polypeptide, or GIP. The company…
ARS Pharmaceuticals launched neffy in November 2025, introducing the first nasal treatment for anaphylaxis approved by the FDA. The product delivers a single dose of…
What if lost teeth could grow back naturally? For centuries, tooth loss has been treated with artificial solutions such as dentures, bridges, or implants. But…
BostonGene was recently recognized with the “AI-based Drug Discovery Solution of the Year” award in the 8th annual AI Breakthrough Awards program, which drew more…
On September 5, 2025, Xpanceo announced a partnership with Italian medtech startup Intra-ker to develop an intracorneal implant capable of embedding a microLED display directly…
TMRW Life Sciences announced on June 10, 2025, that it has acquired Cryogatt Systems’ patent portfolio covering cryogenic storage and RFID-based tracking technologies. The deal…
On July 16, 2025, a U.S. federal judge denied Novartis’ bid for a preliminary injunction aimed at preventing India’s MSN Pharmaceuticals from launching a generic…
